These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Remune trial will stop; new trials planned. James JS AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461 [TBL] [Abstract][Full Text] [Related]
8. Support for the RV144 HIV vaccine trial. AIDS Vaccine Advocacy Coalition Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069 [No Abstract] [Full Text] [Related]
9. [Ethical elements in the development of vaccines against HIV/AIDS]. Molina CN Sidahora; 2001 Oct; ():14-6. PubMed ID: 11776246 [No Abstract] [Full Text] [Related]
10. Questions, questions. The future of HIV research. Huff B GMHC Treat Issues; 2005 Dec; 19(12):4-8. PubMed ID: 16909507 [No Abstract] [Full Text] [Related]
11. Suitability of Trinidad/Tobago as a potential site for phase III efficacy studies of HIV-1 vaccines. Paul R; Cleghorn F; Jack N; Edwards J; Mahabir B; Murphy J; Blattner W; Bartholomew C AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S9. PubMed ID: 7865340 [No Abstract] [Full Text] [Related]
12. Keeping hope alive: HIV vaccines & the community. Montecalvo M Body Posit; 2004; 17(4):15-6. PubMed ID: 15929209 [No Abstract] [Full Text] [Related]
13. The quest for an HIV-1 therapeutic vaccine. Gandhi RT; Altfeld M J Infect Dis; 2005 Aug; 192(4):556-9. PubMed ID: 16028123 [No Abstract] [Full Text] [Related]
14. Bridging the gap between "ABC" and an AIDS vaccine. Laurence J AIDS Read; 2006 Oct; 16(10):502-4. PubMed ID: 17096468 [No Abstract] [Full Text] [Related]